Rolf Barth to Ganciclovir
This is a "connection" page, showing publications Rolf Barth has written about Ganciclovir.
Connection Strength
0.106
-
Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients. HPB (Oxford). 2010 Dec; 12(10):657-63.
Score: 0.092
-
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res. 2003 Mar 01; 63(5):965-71.
Score: 0.014